Recall report of blood pressure drugs ‘misleading’


Share post:

The Royal Pharmaceutical Society (RPS) has confirmed that the recall of blood pressure drugs amlodipine and olmesartan by the Food and Drug Administration is only for the US market and will not have any impact in the UK.

MHRA also clarified that the manufacturer of these drugs, Macleod Pharmaceuticals, does not supply amlodipine medicines in the UK.

It was published online in both the Daily Record and Daily Express on the morning of Monday, March 21, that the drugs had been recalled in the US by the FDA due to deviations from standard manufacturing protocols by the manufacturer.

RPS intervened to ensure the articles were edited to make clear that this is not an issue in the UK after confirmation from the MHRA. Amlodipine tablets from Macleod Pharmaceuticals aren’t available for wholesale distribution in the UK.

An MHRA statement said: “The MHRA has confirmed that the recall of combined Amlodipine/Olmesartan Medoxomil tablets 10 mg/20 mg, batch number BAD62101A (expiry Feb 24), is for the US market only – while Macleods Pharma does supply other medicines to the UK, this particular product is not available here.”

“Patients seeking advice can be reassured that the amlodipine and olmesartan provided by the NHS is not affected by the recall in the USA,” assures RPS.


Please enter your comment!
Please enter your name here

Current Issue October 2023

Related articles

CPE launces new webinar series to support implementation of Pharmacy First service

Each webinar will have policy experts from NHS England and CPPE  Community Pharmacy England (CPE) is organising a series...

Nurses demand fresh negotiations following NHS consultant pay offer

The 5% pay award for NHS nursing staff in England appears “increasingly inadequate” to keep up with inflation...

People in Midlands asked to book winter vaccines by 14 December

Viruses that cause flu and Covid spread more easily as it gets colder, warns NHS England director, Roz...

Preventative oral care advice not always offered to patients, survey reveals

Only 10 per cent of consumers said they would go to their pharmacist when seeking preventative care advice...